IA
ANIK icon

IndexIQ Advisors’s Anika Therapeutics ANIK Stock Holding History

IndexIQ Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,245
Closed -$328K – 1133
2020
Q4 		$328K Buy
7,245
+748
+12% +$28.4K 0.01% 605
2020
Q3 		$230K Buy
6,497
+355
+6% +$12.8K 0.01% 541
2020
Q2 		$232K Buy
+6,142
New +$202K 0.01% 439

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

IndexIQ Advisors's ANIK Position: Q1 2021 in Review

IndexIQ Advisors sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 7,245 shares — an estimated $328K sold.

IndexIQ Advisors first reported a position in ANIK in Q2 2020 and held it in 3 quarters. The position peaked at $328K in Q4 2020. 145 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

  • IndexIQ Advisors reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
  • IndexIQ Advisors sold 7,245 Anika Therapeutics shares in Q1 2021, an estimated $328K.
  • IndexIQ Advisors first reported a position in Anika Therapeutics in Q2 2020 and held it in 3 quarters.
  • IndexIQ Advisors's Anika Therapeutics position peaked at $328K in Q4 2020.
  • 145 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on IndexIQ Advisors's 13F filing for Q1 2021, filed 7 May 2021.